Enalapril and Atenolol in Essential Hypertension: Attenuation of Hypotensive Effects in Combination

References

• Douglas-Jones A P, Cruickshank J M. Once daily dosing with atenolol in patients with mild or moderate hypertension. Brit Med J 1976; i: 990–991
   Google Scholar
• Floras J S, Jones J V, Hassan M O, Sleight P. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol and slow-release propranolol. Brit Med J 1982; 285: 1387–1392
   PubMed Web of Science ®Google Scholar
• Petrie J C, Jeffers T A, Scott A K, Webster J. Dose and duration of response to β-blockers in the treatment of hypertension. Drugs 1983; 25(suppl. 2)26–29
   Google Scholar
• Lund-Johansen P, Omvik P. Long-term hemodynamic effects of enalapril (alone and in combination with hydro-chlorothiazide) at rest and during exercise in essential hypertension. J Hypertension 1984; 2(suppl 2)49–56
   PubMedGoogle Scholar
• Vidt D G. A controlled multiclinic study to compare the antihypertensive effects of MK421, hydrochlorothiazide and MK421 combined with hydrochlorothiazide in patients with. mild to moderate essential hypertension. J Hypertension 1984; 2(suppl 2)81–88
   PubMedGoogle Scholar
• Helgeland A, Strommen R, Hagelund C H, Tretli S. Enalapril, atenolol and hydrochlorothiazide in mild to moderate hypertension. A comparative multicentre study in general practice in Norway. Lancet 1986; 1: 872–875
   PubMed Web of Science ®Google Scholar
• Webster J, Petrie J C, Robb O J, et al. Enalapril in moderate to severe hypertension: a comparison with atenolol. Br J Clin Pharracol 1986; 21: 489–495
   PubMed Web of Science ®Google Scholar
• Chalmers J, Horvath J, Tiller D, Bune A. Effects of timolol and hydrochlorothiazide on blood pressure and plasma renin activity: double-blind factorial trial. Lancet 1976; 2: 328–331
   PubMed Web of Science ®Google Scholar
• Chalmers J P, Wing L MH, Grygiel J J, West M J, Graham J R, Bune A J. Effects of once daily indapamide and pindolol on blood pressure, plasma aldosterone concentration and plasma renin activity in a general practice setting. Europ J Clin Pharmacol 1982; 22: 191–196
   PubMed Web of Science ®Google Scholar
• Andren L, Karlberg B, Ohman P, Svensson A, Asplund J, Hansson L. Captopril and atenolol combined with hydrochlorothiazide in essential hypertension. Br J Clin Pharmacol 1982; 14: 107S–111S
   PubMed Web of Science ®Google Scholar
• Zacest R, Gilmore E, Koch-Weser J. Treatment of essential hypertension with combined vasodilation and beta-adrenergic blockade. N Engl J Med 1972; 286: 617–622
   PubMed Web of Science ®Google Scholar
• Gottlieb T B, Katz F H, Chidsey C A. Combined therapy with vasodilator drugs and beta-adrenergic blockade in hypertension: a comparative study of minoxidil and hydralazine. Circulation 1972; 45: 571–582
   PubMed Web of Science ®Google Scholar
• Sannerstedt R, Stenberg J, Vedin A, Wilhelmsson C, Werkö L. Chronic beta adrenergic blockade in arterial hypertension: hemodynamic influences of dihydralazine and dynamic exercise and clinical effects of combined treatment. Am J Cardiol 1972; 29: 718–723
   PubMed Web of Science ®Google Scholar
• Weinberger M H. Blood pressure and metabolic responses to hydrochlorothiazide, captopril and the combination in black and white mild-to-moderate hypertensive patients. J Cardiovasc Pharmacol 1985; 7: S52–S55
   PubMed Web of Science ®Google Scholar
• Chalmers J P, Wing L MH, West M J, et al. Effects of enalapril and hydrochlorothiazide on blood pressure, renin-angiotensin system and atrial natriuretic factor in essential hypertension: a double-blind factorial cross-over study. Aust NZ J Med 1986; 16: 475–480
   PubMedGoogle Scholar
• MacGregor G A, Markandu N D, Smith S J, Sagnella G A. Captopril: contrasting effects of adding hydrochlorothiazide, propranolol or nifedipine. J Cardiovasc Pharmacol 1985; 7: S82–S87
   PubMed Web of Science ®Google Scholar
• Huang C M, del Greco F, Quintanilla A, Molteni A. Comparison of antihypertensive effects of captopril and propranolol in essential hypertension. JAMA 1981; 245: 478–482
   PubMed Web of Science ®Google Scholar
• Staessen J, Fagard R, Lijnen P, Verschueren L J, Amery A. Double-blind comparison between propranolol and bendro-flumethiazide in captopril-treated resistant hypertensive patients. Am Heart J 1983; 106: 321–328
   PubMed Web of Science ®Google Scholar
• Armitage P. Statistical methods in medical research. Blackwell Scientific Publications, Oxford 1971
   Google Scholar
• Ogihara J, Linuma K, Nishi K, et al. A non-chromatographic non-extraction radioimmunoassay for serum aldosterone. J Clin Endocrinol Metab 1977; 45: 726–731
   PubMed Web of Science ®Google Scholar
• Boyd G W, Adamson A R, Arnold M, James V HT, Peart W S. The role of angiotensin II in the control of aldosterone in man. Clin Sci 1972; 42: 91–104
   PubMed Web of Science ®Google Scholar
• Morris M, Cain M, Russell A, Elliott J, Chalmers J. Direct radioimmunoassay of human plasma atrial natriuretic peptide in various normal and pathophysiological states: increase in renal and cardiac failure and during exercise. Clin Exp Hypertension 1987; A9: 703–718
   Google Scholar
• Bonnin J M, Cain M D, Jose J S, et al. Hypertension due to a renin secreting tumour localised by segmental renal vein sampling. Aust NZ J Med 1977; 7: 630–635
   PubMedGoogle Scholar
• Bulpitt C J, Dollery C T. Side effects of hypotensive agents evaluated by a self administered questionnaire. Brit Med J 1973; 3: 485–487
   PubMed Web of Science ®Google Scholar
• Bulpitt C J, Dollery C T, Carne S. Change in symptoms of hypertensive patients after referral to hospital clinic. Brit Heart J 1976; 28: 121–128
   Google Scholar
• Unger T, Ganten D, Lang R E. Converting enzyme inhibitors: antihypertensive drugs with unexpected mechanisms. Trends in Pharmacol Sci 1983; 4: 514–519
   Web of Science ®Google Scholar
• Watkins J, Abbott E C, Hensby C N, Webster J, Dollery C T. Attenuation of hypotensive effect of propranolol and thiazide diuretics by indomethacin. Brit Med J 1980; 281: 702–705
   PubMed Web of Science ®Google Scholar
• Moore T J, Drantz F R, Hollenberg N K, Koletsky R J, Leboff M S, Swartz S I, Levine L, Podolsky S, Oluhy R G, Williams G H. Contribution of prostaglandins to the antihypertensive action of captopril in essential hypertension. Hypertension 1981; 3: 168–173
   PubMed Web of Science ®Google Scholar